Adult respiratory distress syndrome: do selective anticoagulants help? (Q35627757)

9 August 2017

1 reference

title

Adult respiratory distress syndrome: do selective anticoagulants help? (English)

1 reference

9 August 2017

1 reference

1 reference

Steven Idell

1 reference

9 August 2017

publication date

1 January 2002

1 reference

Treatments in Respiratory Medicine

9 August 2017

published in

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

9 August 2017

page(s)

383-391

1 reference

Anticoagulants for acute respiratory distress syndrome: can they work?

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

The acute respiratory distress syndrome: fibrosis in the fast lane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Fibrin as a component of the tumor stroma: origins and biological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Regulation of extravascular coagulation by microvascular permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Factor VIIIa-induced gene expression: potential implications in pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Local abnormalities of coagulation and fibrinolysis and alveolar fibrin deposition in sheep with oleic acid-induced lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Role of enzymes mediating thrombosis and thrombolysis in lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Local activation of the coagulation and fibrinolysis systems in lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Vascular components of ARDS. Clinical pulmonary hemodynamics and morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

State of the art. The pleura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Abnormalities of pathways of fibrin turnover in the human pleural space

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Medical and surgical treatment of parapneumonic effusions : an evidence-based guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Pathophysiology of disseminated intravascular coagulation in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Thrombin-induced intravascular coagulation: role in vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Pulmonary vascular obstruction in severe ARDS: angiographic alterations after i.v. fibrinolytic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Tissue plasminogen activator for the treatment of deep venous thrombosis of the lower extremity: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Tissue factor pathway inhibitor does not influence inflammatory pathways during human endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Leaky vessels, fibrin deposition, and fibrosis: a sequence of events common to solid tumors and to many other types of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

Fibrin turnover in lung inflammation and neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03257165

21 January 2018

Identifiers

DOI

10.1007/BF03257165

1 reference

9 August 2017

1 reference